Impax Asset Management’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
$463K Buy
10,620
+908
+9% +$42.3K 0.03% 172
2018
Q1
$446K Buy
9,712
+1,307
+16% +$63.4K 0.03% 171
2017
Q4
$425K Buy
8,405
+558
+7% +$29.4K 0.02% 163
2017
Q3
$408K Sell
7,847
-396
-5% -$19.3K 0.02% 167
2017
Q2
$404K Buy
8,243
+897
+12% +$41.6K 0.02% 163
2017
Q1
$346K Buy
7,346
+449
+7% +$21.4K 0.02% 173
2016
Q4
$331K Buy
6,897
+224
+3% +$10.3K 0.02% 166
2016
Q3
$264K Buy
6,673
+337
+5% +$12.7K 0.02% 173
2016
Q2
$225K Buy
6,336
+561
+10% +$21.9K 0.01% 196
2016
Q1
$226K Buy
5,775
+350
+6% +$13.1K 0.01% 199
2015
Q4
$233K Buy
5,425
+225
+4% +$9.89K 0.01% 186
2015
Q3
$219K Hold
5,200
0.01% 183
2015
Q2
$260K Buy
5,200
+408
+9% +$19.3K 0.01% 180
2015
Q1
$216K Buy
4,792
+227
+5% +$10.2K 0.01% 188
2014
Q4
$220K Buy
+4,565
New +$217K 0.01% 189

Other funds holding MET

Impax Asset Management's MET Position: Q2 2018 in Review

Impax Asset Management increased its MetLife (MET) stake by 9.3% in Q2 2018, buying an estimated $42.3K and bringing the position to 10,620 shares worth $463K. The position accounts for 0.03% of the portfolio, ranked #172.

Impax Asset Management first reported a position in MET in Q4 2014 and has held it in 15 quarters since. 1,031 funds tracked by Wall St. Rank hold MET as of Q2 2018.

  • Impax Asset Management held 10,620 shares of MetLife worth $463K as of Q2 2018.
  • Impax Asset Management bought 908 MetLife shares in Q2 2018, an estimated $42.3K.
  • MetLife made up 0.03% of Impax Asset Management's portfolio in Q2 2018, its #172 holding.
  • Impax Asset Management first reported a position in MetLife in Q4 2014 and has held it in 15 quarters since.
  • 1,031 funds tracked by Wall St. Rank held MetLife as of Q2 2018.

Based on Impax Asset Management's 13F filing for Q2 2018, filed 14 Aug 2018.